BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 21632816)

  • 21. Efficacy and safety of intensive insulin therapy for critically ill neurologic patients: a meta-analysis.
    Shan L; Hao PP; Chen YG
    J Trauma; 2011 Nov; 71(5):1460-4. PubMed ID: 22071938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of the growth hormone/insulin-like growth factor-I axis in critically ill children.
    Gardelis JG; Hatzis TD; Stamogiannou LN; Dona AA; Fotinou AD; Brestas PS; Constantopoulos AG
    J Pediatr Endocrinol Metab; 2005 Apr; 18(4):363-72. PubMed ID: 15844470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of octreotide on growth hormone, IGF-I, IGFBP-3, glucagon, cortisol and epinephrine response to insulin-induced hypoglycaemia in insulin-dependent diabetic patients.
    Lunetta M; Di Mauro M; Le Moli R; Nicoletti F
    Diabetes Metab; 1997 Dec; 23(6):524-7. PubMed ID: 9496559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin, insulin-like growth factor I (IGF-I), IGF-binding protein-1, growth hormone, and feeding in the newborn.
    Ogilvy-Stuart AL; Hands SJ; Adcock CJ; Holly JM; Matthews DR; Mohamed-Ali V; Yudkin JS; Wilkinson AR; Dunger DB
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3550-7. PubMed ID: 9768663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness.
    van den Berghe G; Weekers F; Baxter RC; Wouters P; Iranmanesh A; Bouillon R; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3217-26. PubMed ID: 11443192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin-like growth factor-I (IGF-I), insulin-like growth factor binding proteins (IGFBP) and insulin-like growth factor type I receptor in children with various status of chronic renal failure.
    Houang M; Cabrol S; Perin L; Ducos B; Bensman A; Le Bouc Y
    Growth Horm IGF Res; 2000 Dec; 10(6):332-41. PubMed ID: 11161964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual regulation of insulin-like growth factor binding protein-1 levels by insulin and cortisol during fasting.
    Katz LE; Satin-Smith MS; Collett-Solberg P; Baker L; Stanley CA; Cohen P
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4426-30. PubMed ID: 9851789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
    Jensen PB; Hansen TB; Frystyk J; Ladefoged SD; Pedersen FB; Christiansen JS
    Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nutritional and endocrine-metabolic aberrations in amenorrheic athletes.
    Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4301-9. PubMed ID: 8954031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The GH-IGF-IGFBP axis is changed in Turner syndrome: partial normalization by HRT.
    Gravholt CH; Chen JW; Oxvig C; Overgaard MT; Christiansen JS; Frystyk J; Flyvbjerg A
    Growth Horm IGF Res; 2006; 16(5-6):332-9. PubMed ID: 17067837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unequal impact of short-term testosterone repletion on the somatotropic axis of young and older men.
    Gentili A; Mulligan T; Godschalk M; Clore J; Patrie J; Iranmanesh A; Veldhuis JD
    J Clin Endocrinol Metab; 2002 Feb; 87(2):825-34. PubMed ID: 11836328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
    Khorram O; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Free/dissociable insulin-like growth factor (IGF)-I, not total IGF-I, correlates with growth response during growth hormone treatment in children born small for gestational age.
    Bannink EM; van Doorn J; Mulder PG; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2992-3000. PubMed ID: 17504895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The GH Axis in Relation to Accepting an Early Macronutrient Deficit and Outcome of Critically Ill Patients.
    Van Dyck L; Derese I; Vander Perre S; Wouters PJ; Casaer MP; Hermans G; Van den Berghe G; Vanhorebeek I
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5507-5518. PubMed ID: 31361307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intensive insulin therapy versus conventional insulin therapy for critically ill trauma patients admitted to ICU.
    Aldawood AS; Tamim HM; Alsultan MA; Rishu AH; Arabi YM
    Middle East J Anaesthesiol; 2010 Jun; 20(5):659-66. PubMed ID: 20803853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequential changes in insulin-like growth factor I (IGF-I) and IGF-binding proteins in children with end-stage liver disease before and after successful orthotopic liver transplantation.
    Holt RI; Jones JS; Stone NM; Baker AJ; Miell JP
    J Clin Endocrinol Metab; 1996 Jan; 81(1):160-8. PubMed ID: 8550746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of intensive chemotherapy on bone and collagen turnover and the growth hormone axis in children with acute lymphoblastic leukemia.
    Crofton PM; Ahmed SF; Wade JC; Stephen R; Elmlinger MW; Ranke MB; Kelnar CJ; Wallace WH
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3121-9. PubMed ID: 9745414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
    Bannink EM; van Doorn J; Stijnen T; Drop SL; de Muinck Keizer-Schrama SM
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: effect of growth hormone therapy.
    Barreca A; Bozzola M; Cesarone A; Steenbergh PH; Holthuizen PE; Severi F; Giordano G; Minuto F
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3534-41. PubMed ID: 9768660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucokinase activators AZD6370 and AZD1656 do not affect the central counterregulatory response to hypoglycemia in healthy males.
    Norjavaara E; Ericsson H; Sjöberg F; Leonsson-Zachrisson M; Sjöstrand M; Morrow LA; Hompesch M
    J Clin Endocrinol Metab; 2012 Sep; 97(9):3319-25. PubMed ID: 22723318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.